Torii Pharmaceutical Co., Ltd.
TRXPF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $191,431,275 | $199,363,369 | $209,139,370 | $190,952,423 |
| - Cash | $5 | $4 | $3 | $5 |
| + Debt | $0 | $0 | $0 | $1 |
| Enterprise Value | $191,431,270 | $199,363,365 | $209,139,367 | $190,952,419 |
| Revenue | $0 | $15 | $17 | $15 |
| % Growth | -99.2% | -14.1% | 13.8% | – |
| Gross Profit | $0 | $7 | $5 | $7 |
| % Margin | 42.8% | 45.1% | 29.4% | 45.2% |
| EBITDA | $0 | $2 | $2 | $2 |
| % Margin | 10.2% | 12.3% | 13.1% | 11.9% |
| Net Income | $0 | $1 | $2 | $1 |
| % Margin | 7.2% | 9.5% | 8.9% | 8.7% |
| EPS Diluted | 0.3 | 49.48 | 53.97 | 46.39 |
| % Growth | -99.4% | -8.3% | 16.3% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |